24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
Spotlight
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Entera Bio
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
16:16
Full list of Israeli startup M&As in 2025
16:15
Full list of Israeli high-tech funding rounds in 2025
19:09
"Without Mellanox, Nvidia wouldn’t have become a $4 trillion powerhouse"
18:59
Rising AI unicorn Crusoe buys one-year-old Israeli startup Atero in $150M deal
More stories
Buzz
Most popular
Daily
Weekly
1
Rising AI unicorn Crusoe buys one-year-old Israeli startup Atero in $150M deal
2
Michael Levitt Analysis: Corona Is Slowing Down, Humanity Will Survive
3
Seemplicity raises $50 million to automate exposure management with AI
4
E-commerce shifts to AI: Yotpo lays off about 200 employees
5
Inside Nir Zuk’s departure and Palo Alto’s next gamble
More news
Entera Bio
3 stories about Entera Bio
Fourth Time’s the Charm for Entera Bio IPO
01.07.18
|
Dror Reich
The Israel-based oral drug developer listed on Nasdaq on Thursday, pricing 1.4 million units of one share and one warrant at $8 each
Entera Bio Files for Nasdaq IPO
12.11.17
|
Lilach Baumer
The clinical stage company develops treatments mostly for osteoporosis and bone disorders
IPO Hopeful Entera Bio Moves to Better Position
13.09.17
|
Dror Reich
Clinical-stage company Entera Bio develops pioneering technology for orphan disease hypoparathyroidism
